09/24/2012 - 11:49am

CVS Caremark and the Rhode Island Free Clinic have announced a partnership to help the uninsured, working poor in Rhode Island get access to the vital medications they need. Through this collaboration, the clinic’s patients can get prescriptions filled at no cost, and can receive face-to-face pharmacist counseling at three CVS/pharmacy locations in the greater Providence area.

09/24/2012 - 10:20am

As part of CVS Caremark's sponsorship of The Partnership at Drugfree.org's The Medicine Abuse Project, which aims to prevent a half-million teens from abusing medicine over the next five years, the company now is asking its customers to take the project's pledge to learn about teen medicine abuse, to safeguard medicines in the home and to talk to teens about this issue, the company announced on Monday.

09/19/2012 - 3:58pm

CVS Caremark announced that its board of directors has approved a new share repurchase program for up to $6 billion of the company's outstanding common stock.

09/19/2012 - 1:19pm

Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.

09/18/2012 - 3:42pm

While traditional circulars still have their place within retail — especially when it comes to reaching older shoppers — there’s no doubt that the tides are changing as loyalty cards take a greater share of the 
promotional spotlight. 


09/18/2012 - 10:44am

MinuteClinic and OU Physicians, Oklahoma's largest physician group with more than 560 doctors, have entered into a clinical affiliation to enhance access to healthcare services in Oklahoma.

09/17/2012 - 1:23pm

The CVS/pharmacy ExtraCare program, which boasts more than 70 million active members, now gives shoppers the ability to earn bigger rewards on most purchases during the peak fall and winter shopping season.

09/17/2012 - 9:37am

CVS Caremark has appointed Thomas Moriarty as EVP and general counsel of CVS Caremark.

09/12/2012 - 2:03pm

Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.